US6011035A - Calcium channel blockers - Google Patents

Calcium channel blockers Download PDF

Info

Publication number
US6011035A
US6011035A US09/107,037 US10703798A US6011035A US 6011035 A US6011035 A US 6011035A US 10703798 A US10703798 A US 10703798A US 6011035 A US6011035 A US 6011035A
Authority
US
United States
Prior art keywords
halo
independently
alkyl
compounds
6c
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US09/107,037
Inventor
Terrance Preston Snutch
Gerald Werner Zamponi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zalicus Pharmaceuticals Ltd
Original Assignee
Neuromed Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US09/107,037 priority Critical patent/US6011035A/en
Application filed by Neuromed Technologies Inc filed Critical Neuromed Technologies Inc
Assigned to NEUROMED TECHNOLOGIES INC. reassignment NEUROMED TECHNOLOGIES INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SNUTCH, TERRANCE PRESTON, ZAMPONI, GERALD WERNER
Priority claimed from US09/476,927 external-priority patent/US6387897B1/en
Priority claimed from US09/476,928 external-priority patent/US6310059B1/en
Application granted granted Critical
Publication of US6011035A publication Critical patent/US6011035A/en
Priority claimed from US09/818,063 external-priority patent/US6492375B2/en
Priority claimed from US10/409,763 external-priority patent/US6951862B2/en
Priority claimed from US10/409,868 external-priority patent/US6943168B2/en
Priority claimed from US10/655,393 external-priority patent/US7186726B2/en
Priority claimed from PCT/CA2004/000539 external-priority patent/WO2004089922A2/en
Priority claimed from US10/821,389 external-priority patent/US20040266784A1/en
Priority claimed from US10/821,584 external-priority patent/US20040259866A1/en
Priority claimed from US11/214,218 external-priority patent/US20060084660A1/en
Assigned to NEUROMED PHARMACEUTICALS LTD. reassignment NEUROMED PHARMACEUTICALS LTD. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: NEUROMED TECHNOLOGIES INC.
Assigned to ZALICUS PHARMACEUTICALS LTD. reassignment ZALICUS PHARMACEUTICALS LTD. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: NEUROMED PHARMACEUTICALS LTD.
Anticipated expiration legal-status Critical
Application status is Expired - Lifetime legal-status Critical

Links